A Participatory Evaluation of W.H.O Ethical Criteria for Medicinal Drug Promotion in Multiple Countries
Title | A Participatory Evaluation of W.H.O Ethical Criteria for Medicinal Drug Promotion in Multiple Countries PDF eBook |
Author | |
Publisher | |
Pages | |
Release | 1997 |
Genre | Advertising |
ISBN |
A Participatory Evaluation of the Implementation of WHO's Ethical Criteria for Medicinal Drug Promotion in Multiple Countries
Title | A Participatory Evaluation of the Implementation of WHO's Ethical Criteria for Medicinal Drug Promotion in Multiple Countries PDF eBook |
Author | Niyada Kiatying-Angsulee |
Publisher | |
Pages | |
Release | 2004 |
Genre | Drug utilization |
ISBN |
Ethical Criteria for Medicinal Drug Promotion
Title | Ethical Criteria for Medicinal Drug Promotion PDF eBook |
Author | World Health Organization |
Publisher | |
Pages | 32 |
Release | 1988 |
Genre | Business & Economics |
ISBN |
"Resolution WHA41.17 adopted by the Forty-first World Health Assembly, 13 May 1988" -- p.1.
International Ethical Guidelines for Health-Related Research Involving Humans
Title | International Ethical Guidelines for Health-Related Research Involving Humans PDF eBook |
Author | Council for International Organizations of Medical Sciences (CIOMS) |
Publisher | World Health Organization |
Pages | 0 |
Release | 2017-01-31 |
Genre | Bioethics |
ISBN | 9789290360889 |
"In the new 2016 version of the ethical guidelines, CIOMS provides answers to a number of pressing issues in research ethics. The Council does so by stressing the need for research having scientific and social value, by providing special guidelines for health-related research in low-resource settings, by detailing the provisions for involving vulnerable groups in research and for describing under what conditions biological samples and health-related data can be used for research."--Page 4 de la couverture.
WHO guideline on country pharmaceutical pricing policies
Title | WHO guideline on country pharmaceutical pricing policies PDF eBook |
Author | |
Publisher | World Health Organization |
Pages | 70 |
Release | 2020-09-29 |
Genre | Business & Economics |
ISBN | 9240011870 |
In recent years, high prices of pharmaceutical products have posed challenges in high- and low-income countries alike. In many instances, high prices of pharmaceutical products have led to significant financial hardship for individuals and negatively impacted on healthcare systems' ability to provide population-wide access to essential medicines. Pharmaceutical pricing policies need to be carefully planned, carried out, and regularly checked and revised according to changing conditions. Strong, well-thought-out policies can guide well-informed and balanced decisions to achieve affordable access to essential health products. This guideline replaces the 2015 WHO guideline on country pharmaceutical pricing policies, revised to reflect the growing body of literature since the last evidence review in 2010. This update also recognizes country experiences in managing the prices of pharmaceutical products.
Translating Foreign Ideas Into Domestic Practices
Title | Translating Foreign Ideas Into Domestic Practices PDF eBook |
Author | Kristina Jönsson |
Publisher | |
Pages | 230 |
Release | 2002 |
Genre | Pharmaceutical policy |
ISBN |
Registries for Evaluating Patient Outcomes
Title | Registries for Evaluating Patient Outcomes PDF eBook |
Author | Agency for Healthcare Research and Quality/AHRQ |
Publisher | Government Printing Office |
Pages | 385 |
Release | 2014-04-01 |
Genre | Medical |
ISBN | 1587634333 |
This User’s Guide is intended to support the design, implementation, analysis, interpretation, and quality evaluation of registries created to increase understanding of patient outcomes. For the purposes of this guide, a patient registry is an organized system that uses observational study methods to collect uniform data (clinical and other) to evaluate specified outcomes for a population defined by a particular disease, condition, or exposure, and that serves one or more predetermined scientific, clinical, or policy purposes. A registry database is a file (or files) derived from the registry. Although registries can serve many purposes, this guide focuses on registries created for one or more of the following purposes: to describe the natural history of disease, to determine clinical effectiveness or cost-effectiveness of health care products and services, to measure or monitor safety and harm, and/or to measure quality of care. Registries are classified according to how their populations are defined. For example, product registries include patients who have been exposed to biopharmaceutical products or medical devices. Health services registries consist of patients who have had a common procedure, clinical encounter, or hospitalization. Disease or condition registries are defined by patients having the same diagnosis, such as cystic fibrosis or heart failure. The User’s Guide was created by researchers affiliated with AHRQ’s Effective Health Care Program, particularly those who participated in AHRQ’s DEcIDE (Developing Evidence to Inform Decisions About Effectiveness) program. Chapters were subject to multiple internal and external independent reviews.